Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Fibroblast Growth Factor 13 (FGF13) (Middle Region) Peptide

FGF13 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN976828

Quick Overview for Fibroblast Growth Factor 13 (FGF13) (Middle Region) Peptide (ABIN976828)

Target

FGF13 (Fibroblast Growth Factor 13 (FGF13))

Origin

Human

Source

  • 9
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-FGF13 antibody (Catalog #: ARP55412_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    FGF13 (Fibroblast Growth Factor 13 (FGF13))

    Background

    FGF13 is probably involved in nervous system development and function.The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. This gene is located to a region associated with Borjeson-Forssman-Lehmann syndrome (BFLS), a syndromal X-linked mental retardation, which suggests it may be a candidate gene for familial cases of the BFL syndrome. The function of this gene has not yet been determined. Two alternatively spliced transcripts encoding different isoforms have been described for this gene.

    Alias Symbols: FGF2, FHF2, FHF-2, FGF-13

    Protein Interaction Partner: FGF13,SCN8A,MAPK8IP2

    Protein Size: 245

    Molecular Weight

    27 kDa

    Gene ID

    2258

    NCBI Accession

    NM_004114, NP_004105

    UniProt

    Q92913
You are here:
Chat with us!